Dr. David Medvedeff is the CEO of Radence and a seasoned leader in healthcare innovation. He co-founded and served as CEO of Aspen RxHealth, which was acquired by MedImpact. David previously led several successful companies, including Gold Standard, Avatar International, and VUCA Health. Each was acquired by major industry players. Known for driving growth and delivering impact, David has received numerous honors, including the National Prescott Award and the Next Generation Pharmacist Technology Innovator Award. He is also the only two-time recipient of the Pinnacle Award from the American Pharmacists Association Foundation, recognizing lasting contributions to the healthcare field.
